Back to Search Start Over

Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.

Authors :
García-Villaseñor, Elizabeth
Cortés, Jorge E.
Reyes-Cisneros, Oscar A.
Fernández-Gutiérrez, José A.
Sánchez-Bonilla, Daniela
Bojalil-Álvarez, Lorena
Murrieta-Álvarez, Iván
Ruiz-Delgado, Guillermo J.
Ruiz-Argüelles, Guillermo J.
Source :
Leukemia Research. Oct2022, Vol. 121, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

The results of treatment of adolescents and adults with acute lymphoblastic leukemia (ALL) remain unsatisfactory. Pediatric-inspired treatments seem to be related with better outcomes. 126 adolescent and adult patients with ALL were treated in a 37-year period with a pediatric inspired combined chemotherapy (PICC) schedule, delivered on an outpatient basis and based on the St. Jude´s TOTAL XI pediatric protocol employing vincristine, prednisone, asparaginase, daunorubicin, etoposide, cytarabine, methotrexate, mercaptopurine and triple intrathecal therapy. 80 % of patients were able to receive the initial seven-week period of induction / consolidation fully as outpatients and 77 % achieved a complete remission. In adolescents and young adults (AYAs) the median probability of overall survival (OS) was 44 months, whereas the 5-year OS was 48 %. In adults, the median probability of OS was 24 months, and the 5-year OS was 32 %. Patients with T-cell ALL did significantly worse than those with a B cell phenotype (OS at 5 years 17 versus 40 %, respectively). These figures are better than those informed in our country employing more aggressive, in-hospital schedules such as the hyper-CVAD. We found that, in AYAs and adult patients with ALL, the use of an asparaginase-containing PICC delivered on an outpatient basis renders acceptable results, better than those obtained in similar socioeconomic circumstances employing adult-oriented schedules. Additional studies are needed to assess the usefulness of these PICC treatments in adult individuals with ALL treated in underprivileged circumstances, such as those prevailing in LMIC. • Patients with T-cell ALL did significantly worse than those with a B cell phenotype. • The use of pediatric-like regimens in AYAs and adults have shown improved outcomes. • Treatment approaches must be adapted to the socioeconomic conditions of the patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01452126
Volume :
121
Database :
Academic Search Index
Journal :
Leukemia Research
Publication Type :
Academic Journal
Accession number :
159215894
Full Text :
https://doi.org/10.1016/j.leukres.2022.106935